Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing.
Department of Rheumatology and Immunology, the Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi.
Rheumatology (Oxford). 2023 Mar 1;62(3):1216-1226. doi: 10.1093/rheumatology/keac450.
Anti-melanoma differentiation-associated gene 5 positive (anti-MDA5+) DM has a close relationship with rapidly progressive interstitial lung disease (RPILD) and is associated with high mortality. However, data regarding the time-dependent risk of RPILD and deaths during disease progression are limited. We conducted this study to investigate whether the risk of RPILD and death were time-dependent or not in anti-MDA5+ DM.
We assessed a cohort of 272 patients with anti-MDA5+ DM. The clinical characteristics of patients with anti-MDA5+ were collected, and COX regression was used to analyse independent risk factors for RPILD and death. We also described changes in risk of RPILD and death over time and their potential clinical implications.
There were 272 anti-MDA5+ DM patients enrolled in this study. According to the multivariate cox regression analysis, short disease course, high CRP level, anti-Ro52 positive and anti-MDA5 titre (++∼+++) were independent risk factors of RPILD. High creatine kinase level, high CRP level and RPILD were independent risk factors for death, and >90% RPILD and 84% mortality occurred in the first 6 months after disease onset. Notably, the first 3 months is a particularly high-risk period, with 50% of RPILD and 46% of deaths occurring. Hazards regarding RPILD and mortality diminished over time during a median follow-up of 12 months.
These results suggest significant, time-dependent changes in RPILD and mortality risk in anti-MDA5+ DM patients, providing a cut-off time window to estimate disease progression and poor prognosis.
抗黑色素瘤分化相关基因 5 阳性(抗-MDA5+)的糖尿病与快速进展性间质性肺病(RPILD)密切相关,且与高死亡率相关。然而,关于疾病进展期间 RPILD 和死亡的时间依赖性风险的数据有限。我们开展本研究旨在探讨抗-MDA5+DM 中 RPILD 和死亡的风险是否具有时间依赖性。
我们评估了 272 例抗-MDA5+DM 患者的队列。收集患者的抗-MDA5+特征,并采用 COX 回归分析分析 RPILD 和死亡的独立危险因素。我们还描述了 RPILD 和死亡风险随时间的变化及其潜在的临床意义。
本研究共纳入 272 例抗-MDA5+DM 患者。多变量 COX 回归分析表明,病程短、CRP 水平高、抗-Ro52 阳性和抗-MDA5 滴度(++∼+++)是 RPILD 的独立危险因素。高肌酸激酶水平、高 CRP 水平和 RPILD 是死亡的独立危险因素,且>90%的 RPILD 和 84%的死亡率发生在发病后 6 个月内。值得注意的是,前 3 个月是一个特别高风险期,50%的 RPILD 和 46%的死亡发生在这一时期。在中位随访 12 个月期间,RPILD 和死亡率的风险随时间逐渐降低。
这些结果表明抗-MDA5+DM 患者的 RPILD 和死亡率风险存在显著的、时间依赖性变化,为估计疾病进展和不良预后提供了一个截止时间窗口。